Clinical Trial Update: Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pembrolizumab in combination with chemotherapy as frontline treatment for advanced ovarian, primary peritoneal, and fallopian tu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN